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Abstiact. Adequate picscntation and ccll suiiacc cxpiession of foieign minoi histocompatibility antigens
(mHag) to allogcneie Τ cells tan lead to gialt veisus host disease (GvHD) aftei HI Α matched bone
manow tiansplantation (BMT) Cells ol the dendutic cell (DC) hneage including epideimal Langeihans
cells (LC) arc the most potent induceis ol pnmaiy alloieactive Τ cell lesponses in \ivo and m vüio To
exploie the possible IOIC of pcnphcial blood DC and of skin denved LC in the induction of alloimmune
responses against mHag we analysed the functional expiession oi mHag on these piolcssional antigen
piesenting cells (APC) To this end cytotoxic Τ cell (CTL) clones specinc loi mHag Η Υ and HA 1 to
HA 4 weie used to demonstiate the piesencc oi these antigens on highly puufied DC and LC Our lcsults
demonstiatc lhat hke olhei cells ot the hcmatopoietic Imeagc DC and LC expiess all the mHag tested
loi The lunctional cxpiession ol mHag on these potent APC suggests then involvement in the induction
ol mHag specific GvH directed Τ cell lesponses altei allogeneic BMT
Introduction
Gtalt veisus hosl disease (GvHD) IS still a majoi complication
of allogeneic bone manow tiansplantation (BMT) In HLA
matched BMT minoi histocompatibility antigen (mHag) dis
pauties between bone mairow donor and lectpient can play
a role in the development oi Τ cell mediated GvHD ' 9 The
alloiesporse to mHag in vi\o is supposed to be mitiatcd by
piofessional antigen-piesenting cells (APC)
Celh oi the dendiiüc cell (DC) lincage are well charac
tettzed ptofessional APC They are highly efhcient in the
Initiation of pumaiy m \itio Τ cell lesponses such as in allo-
geneic mixed leueocyte leactions λ Moieovei DC pulsed with
protein antigen in \itro or virally infected DC ate capable oi
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pnming antigen specific MHC lestucted Τ cells both in vitio
and in vivo4 c DC aie denved fiom bone maiiow piecmsois
and migiate in an immatuie foim via the blood to the non-
lymphoid ttssues such as the skin 7 9 Epideimal Langeihans
cells (LC) aie the best chatacten/ed nonlymphoid oi mtei
stitial DC They aie lefened to as the peupheial outpost of
the immune System, with a Special lole in the local cutaneous
defence l 0 " Within normal epideimis, LC ate the only cells
that expiess MHC class II molecules and have the capacity to
miüate antigen specific Τ cell lesponses '" p Like lymphoid
DC, LC aie efficient APC in the induction oi Τ cell
lesponses m t Following acquisttton and piocessing oi anti
gens, the LC migiate as veiled cells thiough the affeient lym
phatics into the draining lymph nodes where they become spe-
ciahzed at clustenng and activating naive Τ cells l 2 iS " Α lole
foi LC in the induction of GvHD has been postulated as the
skin is one of the main taiget oigans in GvHD Host LC can
pcisist foi a long time aftei BMT befote the epideimis is
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repopulaled by LC from donor o n g i n 8 1 7 1 8 Furthermore, LC
are the cntical stimulator cells in the in vitro allogeneic epider
mal ceU-lymphocyte reaction, which may be regarded as an
in vitro correldte of the GvH reaction U 2°
Objective
The objective of the present study was to investigate the poss
lble role of penpheral blood DC (as possible precursors of LC)
and LC as potent inducers of the mHag specific GvH directed
Τ cell responses, by evaluating the functional expression of
mHag on these APC mHag generally fall to be recogn^ed by
antibodies We therefore used well-charactenzed mHag spec
lfic CTL clones as effector cells and assayed them against
highly punhed DC and LC as target cells in a cytotoxicity
assay
Material and methods
mHag and MHC class I specific cytotoxic Τ cell
clones
Cytotoxic Τ cell (CTL) clones specific for the mHag Η Υ and
HA-1, HA 2, HA-3 and HA 4 were charactenzed previously
and are descnbed in detail elsewhere ' 2 I The CTL clones
definmg mHag Η Υ, HA 1, HA-2 and HA 4 are HLA-A2
restncted, whereas mHag HA 3 IS lecogm/ed in the context
of HLA AI Thereiore, MHC class I reactive CTL clones
specific for the restnction molecules HLA A2 and HLA AI
were used as control effector cells in the cytotoxicity assays
The charactenstics of the mHag and MHC class I specific CTL
clones are summanzed in Table 1 The CTL clones were
thawed and cultured for 2 days on rIL 2 (recombinant interleu
kin 2, 20 U/ml) betöre being used ds effector cells in a 5 Ι & -
release assay
Isolation of peripheral blood DC
Buffy coats denved from 0 5 1 of blood irom six healthy HLA
and mH antigen typed blood donors were used as source for
peripheral blood mononuclear cells (PBMC) Ennchment for
peripheral blood DC from PBMC was performed accoiding to
the method descnbed by Freudenthal and Steinman 2 2 As a
final step in the dendnüc cell ennchment procedure, cells were
sorted on a fiow cytometer (FACStar, Becton Dickinson)
Cells in the metnzamide low-density fraction were labeled
with a mix of phycoerythnn (PE) conjugated mAb
(monoclonal antibody) specific for CD3, CD 14, CD 16, CD20
and CD56 and fiuorescein (FITC) conjugated mAb specific foi
HLA DR (all fiom Becton Dickinson, Belgium) Cells nega-
tive for the hnedge specific markers and highly positive for
HLA-DR were sorted (Figure la) The sorted cell fraction was
analysed for ultrastructure by elecüon microscopy, and reana-
lysed on a FACScan (Becton Dickinson) to confirm lts punty
Expression of high levels of HLA DP and HLA DQ in
addition to the absence of hneage specific markers (other than
used for sorting, ι e CD2, CD33, CD57 and CD19) was used
to stdin the sorted DC
Isolation of Langerhans cells from epidermal cell
suspensions
Epidermal cell suspensions were obtdined from skin of five
female patients undergoing reconstructive plastic surgery of
the breast or abdomen and were piepaied as descnbed by
Stingl et al 2 3 The patients could not be prospectively typed
for HLA and mH antigens The epidermal cell suspensions
were stained for CDla (OKT6 from Ortho Didgnostics) and
processed on a FACStar Cells which were highly positive for
CDla were sorted (Figuie lb) The sorted cell fraction was
reanalysed on d FACScan and for ultrdstructure by electron
microscopy Ultrathin cryosections were incubated with anü
HLA class II mAb (PdV5 2) conjugated to 10 nm colloiddl
gold particles 24
Table 1 Chdiaclcnstics ol mHag and MHC class I specific CTL clones used
CTL Hone
designation
cl 2
3E2
3HA15
5H13
5HO11
5G30
1R35
HLA"
reslnclion/speci ficity
AI
A2
A2
A2
AI
A2
A2
mH antigen
Code
HA I
HA 2
HA 3
HA 4
Η Υ
Phenotype
frequency (%)
69
94
88
16
Male
Tissued distnbution
Hematopoietic
Hematopoielic
Ubiquitous
Ubiqiutous
Ubiquitous
From Goulmy1 and Van Eis et al2'
' The CTL clones used in this study recogm/e mHag in association wilh cither HLA AI (5HO11)
or HLA A2 (3HA15 5H13 5G30 and 1R35)
Phenotype (requencies of the mHag in the HLA AI (HA 3) oi HLA A2 (HA 1 HA 2 HA 4 Η
Υ) positive heallhy population
'From De Bueger et al1" cell types denved irom seveial tissues were analysed ior then mHag
expression The tissue distnbution of HA I and HA 2 was restncled to cells ol the hematopoietic
hneage (PHA blasts EBV LCL punfied Τ cells Β celis monocytes and immaUiic thymocytes),
while mHag HA 3 HA 4 and Η Υ were detected on all tissues tested hematopoietic and
nonhematopoietic cells (cultured fibioblasts keiatinocytes melanocytes eultuied epithehal cells oi
kidney proximal tubuh and umbilical coid vein denved endothehal cells)
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l<igure 1 Sortmg paramelers tor the Isolation of penpheial blood DC and epidermal LC (a) Expiession of high levels of HLA DR (FL 1) in
addition to the absence of hneage specific markers (FL 2) were used as sortmg paiametcrs (lowei nght quadiant) to punty the ennched DC
fractions (b) Langeihans cells were sorted fiom epidermal cell suspensions 1 2% of the Single cell suspensions stained foi the LC specific market
CDla (FL 1)
Figure2 FACS analysis of the soited penpheial blood DC Sorted DC were stained with mAb spccihc foi HLA DP (B7 21 Becton Dickmson)
and HLA DQ (SPvL3 fiom Η Spits) for B7 1 and foi the hneage specific markers CD2 CD 19 and CD33 followed by PE con|ugaled goat anti
mouse mAb (background peak)
Cytotoxicity assay
Expression of the CTL defined mHag on punhed penpheial
blood DC and LC was analysed in a standaid 4 h "Ci lelease
assay FACS-sorted DC and LC were used as target cells foi
the mHag and MHC class I specific CTL clones in effectoi to
taiget ratios of 20 1 and 2 1 LC weie ineubated with IFN-γ
(inteifeion gamma) 200 U/ml foi 48 h at 37°C before being
used as target cells Percentages of specific 5 1Cr lelease weie
calculated as follows
% lysis =
expenmental lelease — spontaneous release
maximal lelease - spontaneous lelease
— x 100
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in which the spontaneous s l Ci release by the different taiget
cells is always lower than 20% FACS sorted DC, pure frac
tions oi monocytes (> 95% CD14 positive) and phytohemag
glutiiun (PHA) stimulated Τ cell blasts from the same blood
donor were tested simultaneously as target cells
Results
Purity of the FACS-sorted DC and LC
FACS sorting piovided hjgh punty of both DC and LC FACS
analysis of the sorted DC and LC revealed that > 95% of the
cells expressed relatively high amounts of HLA DP and HLA
DQ and were positive for B7 1 analogous to whal was
descnbed e a j h e r 2 2 " the soited DC were negative for hneage
specific markers such as CD2 CD 19 and low positive for
CD33 (Figure 2) Ultrastructural analysis of the soited DC
(Figure 3) and LC (Figure 4a) demonstrated that these teils
both displayed the specihc chaiactenstics such as long cyto
plasmic piocesses and a lobulated nucleus the sorted CDla
positive cells clearly displayed Birbeck granules (Figure 4a
inset) Immunoelectron microscopy revealed a relatively high
expression of class II molecules on the LC, both intracellularly
(Figure 4b) and on the cell surface (data not shown) Ultra
structural and FACS analysis of the sorted LC fuithermoie
demonstiated that the few keratinocytes contaminating the
fractions weie not viable
mHag and HLA expression of peripheral blood DC
Punhed preparations of penpheial blood DC from six blood
donors weie analysed for expression of the mHag Η Υ and
HA 1 HA 2 HA 3 and HA 4 and of the relevant rcstnction
molecules HLA A2 and HLA AI DC as well as PHA blasts
and monocytes of each individual were assayed simul
taneously as target cells with mHag and MHC class I specific
CTL The specific lysis percentages of the target cells irom
three of the six donois aie depicted in Table 2 1t is clear that
DC were equally suscepüble to lysis by the different CTL
clones as the PHA blasts and monocytes oi the same donor
Thus analogous to PHA blasts and monocytes the mHag
f
s /
m Λ —
Tigure3 Eloction micrograph oi the sorted CD3 CDI4 CD16
CD20 CD56 negative HLA DR positive cells showing the
chciractcnstics morphology ol DC such as cytoplasmic processes and
d lobuldted nucleus Bar = 2 (xm
I(igure4 (a) EIcction microgiaphs ol sorted CD1 positive cells
showing LC wilh specific charactensücs such as long cytoplasmic
piocesses a lobulated nucleus and Bnbcck granules (inset bar =
0 5 μηι) in the cytoplasm ol the sorted CD1 positive cells Bai - 2 μιη
(b) Incubation ol ultrathin ciyoscctions with anli HLA class II mAb
(PdV5 2) conjugaled to 10 nm colloidal gold particles24 levealcd a
relatively high HLA class II expicssion on lnliaccllulai vesicular
stuictuies ol the sorted LC Bnbeck gianules weit negat/vc Β tr —
0 5 μηι
HA 1 HA 2 HA 3 H A 4 and Η Υ are clearly recognized on
peripheral blood DC
mHag and HLA expression of epidermal LC
Pure pieparations of LC obtained fiom five temale individuals
were analysed foi expression of the mHag HA 1 HA 2 and
HA 3 and for their relevant restnction moJecules HLA A2 and
HLA AI As LC weie obtained solely liom female individ
uals expression of the male specific mHag Η Υ could not be
analysed Table 3 shows the specific lysis percentages of the
Γι anspinnt Immunology 1996 4 151-157
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Table 2 Lysis of penpheral blood DC by mHag and MHC class I specific CTL
mH/MHCl> specihcity
ET"
20
2
20
2
20
2
20
2
20
2
20
2
20
2
Individuals'
D-A-
PHA
83'
75
82
63
71
62
47
28
93
81
0
1
83
76
Mono
48
27
56
30
35
11
30
12
69
38
- 4
=,
44
31
DC
81
61
83
52
68
50
45
26
85
67
0
0
77
73
D-B
PHA
6
3
60
41
79
75
43
38
0
- 3
82
76
-1
0
Mono
nt
nt
43
15
60
51
34
24
-2
0
67
45
nt
nt
DC
nt
nt
77
55
104
79
73
64
1
4
93
88
nt
nt
D-C
PHA
7
7
82
63
50
40
35
26
3
0
1
-1
57
51
Mono
nt
nt
57
20
31
25
36
18
6
0
2
nt
32
20
DC
0
0
61
60
52
23
38
22
nt
nt
2
nt
41
40
HLA AI
HLA A2
HA-1
HA 2
HA-3
HA-4
H-Y
' PHA stimulated Τ cell blasts (PHA), monocytes (mono) and dendntic cells (DC) are tested simultaneously as target for lysis by mH specific CTL
b
 Antigen specificity of the clones used (see Table 1 for further Information)
°HLA type of individual D-Α (male), AI,2, B7,8, Cw7, DR.15,3, DQ1.2, DPwl,w4, individual D-B (female), A2, B27, 40, Cw2,w3, DR11,12, DQ3,
DPw4, individual D-C (male), A2,24, B44,62, Cw3,w5, DR 13,4, DQ3,6 DPw3
d
 Effector target latio used in the "Cr release assay
° Percentages of specific lysis in a 4-h "Cr-release assay
Table 3 Lysis of epidermal Langerhans cells by mHag and MHC class I
specific CTL
mH/MHC
specificity0
HLA-Al
HLA-A2
HA-1
HA-2
HA-3
E T
20
2
20
2
20
2
20
2
20
2
b
 Individuals0
L-A
_ d
21 e
18
2
0
3
1
0
0
19
12
+
71
nt
7
nt
5
nt
3
nt
83
nt
L-B
+
5
0
48
nt
32
23
35
31
0
0
L-C
+
0
0
51
42
57
38
32
21
2
0
L-D
+
3
0
61
42
i l
nt
76
43
5
1
L-E
+
93
87
74
67
72
59
64
43
72
70
I
 LC were obtained from epidermal cell su^pensions from skin of five
individuals
b
 Effector target ratio used in the 51Cr-release assay
c
 Antigen specificity of the clones used (see Tablt 1 foi lurther
Information)
II
 LC were used as taiget for mHag specific lysis after pieincubation with
(+) IFN-γ, LC of individual L-A are tested for lysis susceptibihty aftei
preincubation with (+) and without (-) 1FN -y
*-Percentages of specific lysis in a 4 h '"Cr-release assay
LC from the five individuals by the different CTL clones LC
of individual L-A were tested as target cells after a 48-h meu-
bation with and without IFN-7 The viability of the LC frac-
tion was maintained dunng this eulture Step, in which no other
cytokines were added Prelimmary FACS analyses of LC of
individual L-A, ineubated with or withuot IFN-7, revealed a
significant increase in the expression of ICAM-1, B7-1 and
MHC molecules on the surface of the LC after IFN-γ lncu-
bation (data not shown) Although freshly isolated LC were
susceptible to mHag specific lysis by CTL clones (individual
L-A~), the lysis susceptibihty was markedly enhanced by pre-
meubatmg the LC for 48 h with IFN-7 200 U/ml (individual
L-A+) Therefore, LC of individuals L-B, L-C, L-D and L-E
were preincubated with IFN-γ before being used as target
cells The LC are found to functionally express the mHag HA-
1, HA-2 and HA-3 (Table 3)
Discussion
The influence of mHag mismatches between bone marrow
donoi and recipient on the development of GvHD after HLA
genotypically identical BMT' was recently confirmed in a pro-
spective multicentre study Mismatches for mHag HA-1, -2,
-4, or -5 was observed to be sigmficantly associated with the
oecurrence of GvHD 2 6 The induction of Τ cell responses to
mHag mismatches will depend largely on the type of APC by
which the antigens are presented Namely, when the Τ cell
receptoi/MHC interaction IS not aided by appropnate costimu-
latoiy Signals, the Τ cell can be anergized and will be unre-
sponsive to subsequent ttiggenng by professional APC Non-
Tranipiant Immunology 1996, 4 151-157
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Professional APC such as keratinocytes and fibroblasts have
been found to induce Τ cell tolerance to the mHdg they
express 2 7 Therefore, the induction of mHag specific Τ cell
lesponses after BMT IS supposed to be controlled by pro
fessional APC, expressing high levels of costimulatory mol-
ecules Cells of the DC hneage, incJuding interstitial DC such
as LC, are descnbed to be the most potent APC in the induc
tion of pnmary Τ cell responses both in vitro and in vivo 6 l 0 "
The high levels of MHC molecules and the expression of
costimulatory molecule B7-1 on the surface of these pro-
fessional APC after activation22 2 g " (Figure 2) contnbute to
then supenor antigen-presentmg capacity
The expression of mHag on penpheral blood DC and LC,
as descnbed m the present study, could indicate a role for cells
of the DC hneage in the Initiation of mHag specific Τ cell
responses in GvHD Although the recipient is depleted for
most hematopoietic denved cells pnor to the BMT, residual
host leucocytes including cells of the DC hneage are still pre-
sent at the moment of BMT In the skin, residual host LC can
persist for a long time after BMT before the host epidermis is
lepopulated by LC of donor ongin n
On the one hand, with then supenor antigen-presenting
capacity, these residual hosl mHag expressing cells of the DC
hneage might be involved in the pnmaiy induction of GvH
directed mHag specific Τ cell responses aftei BMT Host LC
migrating from the skin through the afferent lymph into the
draining lymph nodes, upregulatmg the expression of MHC
and accessory molecules, could stimulate the naive donor
denved Τ cells they encounter 2 4~6 Once sensiti/ed by the
mHag expressing DC or LC, the activated Τ cells could readily
interact with other mHag positive cells, such as keratinocytes
in the skin 3 0
On the other hand, the residual host DC and LC may func-
tion as target cells for, or restimulate already sensiti/ed, mHag
specific Τ cells in GvHD Τ cells of donor ongin may be
pnmed by residual host leucocytes in the circulation, and
reactivated by the most potent APC in the skin, the LC
Decreased numbers of LC in the skin dunng the course of
cutaneous GvHD, as was shown in immunohistochemical
studies, suggest a role of LC as target cells l 8 3 1 In that case,
the damage to keratinocytes may be a nonspecihc effect of
lymphokine release dunng the lymphocyte/LC interactions
Studies on munne LC indicate low or absence of expiession
of at least some MHC class I on the surface of LC, making
them less susceptible to alloreactive cytotoxic Τ cell attack 3 2
In our piesent study, we found that the low lysis susceptibihty
of freshly isolated human epidermal LC by MHC class I and
mHag specific CTL clones was upregulated after incubation
with IFN-7 Prehminary FACS analyses revealed that IFN-7
may enhance CTL recognition by the upregulation oi MHC
molecules, B7 1 and adhesion molecules such as ICAM-1 As
there were no other cytokines added to the culture and no
viable cytokine-producing cells such as keratinocytes could be
detected in the sorted fraction, we ascnbe this effect solely to
IFN 7 The in situ release of IFN-γ dunng cutaneous GvHD1 3
may thus effectively enhance the recognition of LC by mHag
specific CTL clones after BMT, although the data presented
m this study cannot directly be extrapolated to an in vivo role
of the mHag specific CTL in the GvHD pathogenesis Our
study on the functional recognition of mHag on LC and DC
links up with previous studies on the tissue distnbution of
mHag 3 0 The results of this study demonstrate that, hke other
cells of the hematopoietic hneage, DC and LC express all the
Transplant Immunology 1996,4 151-157
mHag we tested for (1 e Η Υ and HA-1 to HA-4 on the penph-
eral blood DC, and HA-1, HA 2 and HA-3 on the epidermal
LC) The expiession of mHag on LC and DC strongly suggests
a possible involvement of cells of the DC hneage m GvH
duected mHag specific Τ cell responses after allogeneic BMT
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